| Literature DB >> 30811790 |
Myriam Almeida-Jones1,2, Nai Yu Tang1,2, Aneela Reddy3, Evan Zahn1,2.
Abstract
Clinically significant patent ductus arteriosus (PDA) has been associated with significant morbidity in extremely low birth weight (ELBW) infants. Current management of ELBW infants with hemodynamically significant PDA includes supportive treatment, pharmacological therapy, and surgical ligation. All of these therapeutic options have their advantages and limitations. More recently, transcatheter PDA closure has been described as a viable option in this population. In this paper, we provide a comprehensive review of this emerging procedure.Entities:
Keywords: device occlusion; extremely low birth weight infant; patent ductus arteriosus
Mesh:
Year: 2019 PMID: 30811790 DOI: 10.1111/chd.12712
Source DB: PubMed Journal: Congenit Heart Dis ISSN: 1747-079X Impact factor: 2.007